Oncology Generic Medicines for NHS Scotland

Oncology Generic Medicines for NHS Scotland

his Framework Agreement is for the supply of Oncology Generic Medicines to NHS Scotland.

UK-Larkhall: pharmaceutical products

2012/S 136-226864

Contract notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

The Common Services Agency (more commonly known as NHS National Services Scotland) (“the Authority”)
National Procurement, Canderside, 2 Swinhill Avenue
Contact point(s): National Procurement
For the attention of: Stuart Gillespie
ML9 2QX Larkhall
UNITED KINGDOM
Telephone: +44 1698794585
E-mail: stuart.gillespie@nhs.net
Fax: +44 1698794403

Internet address(es):

General address of the contracting authority: http://www.nationalprocurement.scot.nhs.uk/

Address of the buyer profile: http://publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

Further information can be obtained from: The Common Services Agency (more commonly known as NHS National Services Scotland) (“the Authority”)
National Procurement, Canderside, 2 Swinhill Avenue
Contact point(s): National Procurement
For the attention of: Stuart Gillespie
ML9 2QX Larkhall
UNITED KINGDOM
Telephone: +44 1698794585
E-mail: stuart.gillespie@nhs.net
Fax: +44 1698794403
Internet address: http://www.nationalprocurement.scot.nhs.uk/

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The Common Services Agency (more commonly known as NHS National Services Scotland) (“the Authority”)
National Procurement, Canderside, 2 Swinhill Avenue
Contact point(s): National Procurement
For the attention of: Stuart Gillespie
ML9 2QX Larkhall
UNITED KINGDOM
Telephone: +44 1698794585
E-mail: stuart.gillespie@nhs.net
Fax: +44 1698794403
Internet address: http://www.nationalprocurement.scot.nhs.uk/

Tenders or requests to participate must be sent to: The Common Services Agency (more commonly known as NHS National Services Scotland) (“the Authority”)
National Procurement, Canderside, 2 Swinhill Avenue
Contact point(s): National Procurement
For the attention of: Stuart Gillespie
ML9 2QX Larkhall
UNITED KINGDOM
Telephone: +44 1698794585
E-mail: stuart.gillespie@nhs.net
Fax: +44 1698794403
Internet address: http://www.nationalprocurement.scot.nhs.uk/

I.2)Type of the contracting authority

Body governed by public law
I.3)Main activity

Health
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Golden Jubilee Hospital (National Waiting Times Centre Board)

NHS 24

NHS Ayrshire and Arran

NHS Borders

NHS Dumfries and Galloway

NHS Education for Scotland

NHS Fife

NHS Forth Valley

NHS Grampian

NHS Greater Glasgow and Clyde

NHS Health Scotland

NHS Highland

NHS Lanarkshire

NHS Lothian

NHS Orkney

NHS Shetland

NHS Tayside

NHS Western Isles

Scottish Ambulance Service

The Common Services Agency for the Scottish Health Service (a.k.a the NHS National Shared Services)

The State Hospital for Scotland

Healthcare Improvement Scotland

Section II: Object of the contract

II.1)Description
II.1.1)Title attributed to the contract by the contracting authority:

NP39712 Oncology Generic Medicines.
II.1.2)Type of contract and location of works, place of delivery or of performance

Supplies
Purchase
Main site or location of works, place of delivery or of performance: Any or all locations of all NHS Scotland Health Boards, all NHS Scotland Special Health Boards and/or the Authority (altogether hereinafter referred to as “NHS Scotland”).
NUTS code UKM

II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves the establishment of a framework agreement
II.1.4)Information on framework agreement

Framework agreement with a single operator
Duration of the framework agreement

Duration in months: 24
Estimated total value of purchases for the entire duration of the framework agreement

Estimated value excluding VAT:
Range: between 2 500 000 and 3 500 000 GBP

II.1.5)Short description of the contract or purchase(s)

This Framework Agreement is for the supply of Oncology Generic Medicines to NHS Scotland.
To access the tender documents for this contract notice, please click on the attached link. This will take you to the tender module within Public Contracts Scotland. This will allow you to access and respond to this contract opportunity in a secure environment. Note: If you do not have a password for the tender module then you will be asked to apply for a login.
(www.publictendersscotland.publiccontractsscotland.gov.uk).

II.1.6)Common procurement vocabulary (CPV)

33600000, 33690000, 33652000, 33652100, 33652300, 33650000

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.1.8)Lots

This contract is divided into lots: yes
Tenders may be submitted for one or more lots
II.1.9)Information about variants

Variants will be accepted: no
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:

A framework agreement for the supply of Oncology Medicines to NHS Scotland. The framework agreement will be a single supplier framework. The framework agreement will be split into twenty eight Lots. Lot 1-27 – Each of the product lines included within these lots will be grouped together and awarded to a single supplier for the full lot requirement. Lot 28 – Each product line will be treated as an individual lot.
The individual descriptions and quantities are detailed within the tender documentation.
Estimated value excluding VAT:
Range: between 2 500 000 and 3 500 000 GBP
II.2.2)Information about options

Options: yes
Description of these options: The Authority is entitled at its sole discretion to extend the 24 month duration of the Framework Agreement by up to a further 12 months by giving a minimum of 3 month’s written notice of such extension and by up to a further 12 months by giving a minimum of 3 month’s written notice of such extension.
II.2.3)Information about renewals

This contract is subject to renewal: yes
Number of possible renewals: 2
II.3)Duration of the contract or time limit for completion

Starting 1.2.2013. Completion 31.1.2015

Information about lots

Lot No: 01 Lot title: Carboplatin Injection

1)Short description

Supply of Carboplatin Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Carboplatin Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 02 Lot title: Cisplatin Injection

1)Short description

Supply of Cisplatin Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Cisplatin Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 03 Lot title: Cyclophosphamide Injection

1)Short description

Supply of Cyclophosphamide Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Cyclophosphamide Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 04 Lot title: Cytarabine Injection

1)Short description

Supply of Cytarabine Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Cytarabine Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 05 Lot title: Dacarbazine Injection

1)Short description

Supply of Dacarbazine Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Dacarbazine Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 06 Lot title: Disodium Folinate Injection

1)Short description

Supply of Disodium Folinate Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Disodium Folinate Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 08 Lot title: Doxorubicin Hydrochloride Injection

1)Short description

Supply of Doxorubicin Hydrochloride Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Doxorubicin Hydrochloride Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 09 Lot title: Epirubicin Solution

1)Short description

Supply of Epirubicin Solution to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Epirubicin Solution to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 10 Lot title: Etoposide Injection

1)Short description

Supply of Etoposide Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Etoposide Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 12 Lot title: Fluorouracil Injection (50mg/ml)

1)Short description

Supply of Fluorouracil Injection (50mg/ml) to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Fluorouracil Injection (50mg/ml) to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 11 Lot title: Fluorouracil Injection (25mg/ml)

1)Short description

Supply of Fluorouracil Injection (25mg/ml) to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Fluorouracil Injection (25mg/ml) to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 13 Lot title: Gemcitabine Powder For Solution For Infusion

1)Short description

Supply of Gemcitabine Powder For Solution For Infusion to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Gemcitabine Powder For Solution For Infusion to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

Potential Framework Participants must submit a minimum of two (2) presentations of Gemcitabine Injection on this tab of the tender schedule. Where a different price per milligram is submitted for different presentations an overall average price per milligram will be used for analysis.
Lot No: 07 Lot title: Docetaxel Concentrate

1)Short description

Supply of Docetaxel Concentrate to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Docetaxel Concentrate to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

Potential Framework Participants must at a minimum tender for the 20MG and 80MG presentations of Docetaxel Injection on this tab of the tender schedule. Where a different price per milligram is submitted for different presentations an overall average price per milligram will be used for analysis.
Lot No: 14 Lot title: Idarubicin Hydrochlioride Injection Powder For Reconstitution

1)Short description

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 15 Lot title: Ifosfamide Injection Powder For Reconstitution

1)Short description

Supply of Ifosfamide Injection Powder For Reconstitution to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Ifosfamide Injection Powder For Reconstitution to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 16 Lot title: Irinotecan Hydrochloride Injection

1)Short description

Supply of Irinotecan Hydrochloride Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Irinotecan Hydrochloride Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

Potential Framework Participants must at a minimum tender for the 40MG, 100MG presentations and either the 300MG presentation or 500MG presentation of Irinotecan Injection on this tab of the tender schedule. Where a different price per milligram is submitted for different presentations an overall average price per milligram will be used for analysis.
Lot No: 17 Lot title: Lanreotide Injection Prefilled Syringe

1)Short description

Supply of Lanreotide Injection Prefilled Syringe to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Lanreotide Injection Prefilled Syringe to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 18 Lot title: Mesna Injection

1)Short description

Supply of Mesna Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Mesna Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 19 Lot title: Methotrexate Injection Pre-Filled Syringe

1)Short description

Supply of Methotrexate Injection Pre-Filled Syringe to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Methotrexate Injection Pre-Filled Syringe to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 20 Lot title: Methotrexate Without Preservatives Injection

1)Short description

Supply of Methotrexate Without Preservatives Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Methotrexate Without Preservatives Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 22 Lot title: Octreotide Injection

1)Short description

Supply of Octreotide Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Octreotide Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 21 Lot title: Mitomycin Injection Powder For Reconstitution

1)Short description

Supply of Mitomycin Injection Powder For Reconstitution to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Mitomycin Injection Powder For Reconstitution to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 23 Lot title: Oxaliplatin Vial Solution

1)Short description

Supply of Oxaliplatin Vial Solution to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Oxaliplatin Vial Solution to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 24 Lot title: Paclitaxel Concentrate For Intravenous Infusion

1)Short description

Supply of Paclitaxel Concentrate For Intravenous Infusion to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Paclitaxel Concentrate For Intravenous Infusion to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 25 Lot title: Temozolomide Capsules

1)Short description

Supply of Temozolomide Capsules to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Temozolomide Capsules to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 26 Lot title: Topotecan Concentrate For Solution For Infusion

1)Short description

Supply of Topotecan Concentrate For Solution For Infusion to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Topotecan Concentrate For Solution For Infusion to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 27 Lot title: Vinorelbine Injection

1)Short description

Supply of Vinorelbine Injection to Health Boards across NHS Scotland.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of Vinorelbine Injection to Health Boards across NHS Scotland. Quantities are detailed in the ITT.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots
Lot No: 28 Lot title: All other Product Presentations

1)Short description

Supply of all other product lines to Health Boards throughout NHS Scotland.
The comprehensive product list will be detailed within the tender schedule.
2)Common procurement vocabulary (CPV)

33600000

3)Quantity or scope

Supply of all other product lines to Health Boards throughout NHS Scotland.
The comprehensive product list and quantities will be detailed within the ITT.
Please note that each product line will be awarded to a single supplier on a line by line basis.
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

Please note that each product line will be awarded to a single supplier on a line by line basis.

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

The Prime Contractor shall be liable in the event of a consortium bid.
III.1.4)Other particular conditions

The performance of the contract is subject to particular conditions: no
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

Information and formalities necessary for evaluating if the requirements are met: In accordance with the Public Contracts (Scotland) Regulations 2012 the Authority shall treat as ineligible and shall not select any economic operator on one of more of the grounds set out below. Accordingly economic operators MUST in each case confirm whether or not the economic operator, any of its directors or any other person who has power of representation, decision or control over the economic operator has been convicted of any of the following offences:
(a) the common law offence of conspiracy where that conspiracy relates to participation in a criminal organisation as defined in Article 2 of Council Framework Decision 2008/841/JHA or an offence under sections 28 or 30 of the Criminal Justice and Licensing (Scotland) Act 2010;
(b) corruption within the meaning of section 1(2) of the Public Bodies Corrupt Practices Act 1889 or section 1 of the Prevention of Corruption Act 1906, where the offence relates to active corruption as defined in Article 3 of the Council Act of 26.5.1997 and Article 3(1) of Council Joint Action 98/742/JHA;
(c) bribery or corruption within the meaning of sections 68 and 69 of the Criminal Justice (Scotland) Act 2003 where the offence relates to active corruption, or bribery within the meaning of sections 1 or 6 of the Bribery Act 2010;
(d) the common law offence of incitement to commit a crime;
(e) fraud, where the offence relates to fraud affecting the financial interests of the European Communities as defined by Article 1 of the Convention relating to the protection of the financial interests of the European Communities, within the meaning of:
(i) the offence of cheating the Revenue;
(ii) the common law offence of fraud;
(iii) the common law offence of theft or fraud;
(iv) fraudulent trading within the meaning of section 458 of the Companies Act 1985 or section 993 of the Companies Act 2006;
(v) fraudulent evasion within the meaning of section 170 of the Customs and Excise Management Act 1979 or section 72 of the Value Added Tax Act 1994;
(vi) an offence in connection with taxation in the European Union within the meaning of section 71 of the Criminal Justice Act 1993;
(vii) the common law offence of uttering; or
(viii) the common law offence of attempting to pervert the course of justice;
(f) money laundering within the meaning of section 340(11) of the Proceeds of Crime Act 2002 or the Money Laundering Regulations 2007, or an offence in connection with proceeds of drug trafficking within the meaning of sections 49, 50 or 51 of the Drug Trafficking Act 1994; or
(g) any other offence within the meaning of Article 45(1) of the Public Sector Directive as defined by the national law of any relevant state.
In accordance with the Public Contracts (Scotland) Regulations 2012 the Authority may treat as ineligible or decide not to select any economic operator on one or more of the grounds set out below. Accordingly economic operators MUST in each case confirm whether or not any of the following apply, namely:
(a) Has the economic operator been declared bankrupt?
(b) Has the economic operator has a debt relief order made against it/him/her?
(c) Has the economic operator had a receiving order or an administration order or bankruptcy restrictions order or a debt relief restriction order made against it/him/her?
(d) Has the economic operator made any composition or arrangement with or for the benefit of creditors or made any conveyance or assignation for the benefit of its creditors?
(e) Has the economic operator appeared unable to pay or has no reasonable prospects of being able to pay a debt within the meaning of Section 268 of the Insolvency Act 1986?
(f) Has the economic operator granted a Trust Deed for creditors or become otherwise apparently insolvent?
(g) Is the economic operator the subject of a petition presented for sequestration of its/his/her estate?
(h) Has the economic operator passed a resolution within, or is it the subject of an order by the court for the winding up of the economic operator, otherwise than for bona fide reconstruction or amalgamation?
(i) Is the economic operator subject of any proceedings similar to those listed in paragraphs (a) to (g) above under the laws of any other state?
(j) Has been convicted of a criminal offence relating to the conduct of the economic operator’s business or profession?
(k) Has the economic operator committed an act of grave misconduct in the course of that economic operator’s business or profession?
(l) Has failed to fulfill obligations relating to the payment of Social Security contributions under the law of the United Kingdom or the relevant state in which the economic operator is established?
(m) Has failed its/his/her obligations relating to payment of taxes under the law of any part of the United Kingdom or the relevant state in which the economic operator is established?
(n) is the economic operator guilty of serious misrepresentation in providing any information required of that economic operator under the Public Contracts (Scotland) Regulations 2012.
III.2.2)Economic and financial ability
III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
Please refer to the tender document for all required information.
Minimum level(s) of standards possibly required:
(a) Potential Framework Participants must agree to the terms of the Supply / Support Specification.
(b) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMEA Marketing Authorisation that has been approved by the MHRA for all Goods tendered at the date of submission of the tender.
(c) The successful Framework Participant(s) and any sub-contractor(s) must possess valid certification of BS EN ISO9001 or equivalent.
(d) Potential Framework Participant’s Goods will be evaluated against the principles of the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (“NPSA”) Guidelines on Packaging and Labelling on a Pass/Fail basis by a representative from Scottish Pharmacy Quality Assurance Group (“SPQAG”).
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure

Open
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria
IV.2.1)Award criteria

Lowest price
IV.2.2)Information about electronic auction

An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:

NP39712
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate

29.8.2012 – 12:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender

Duration in months: 3 (from the date stated for receipt of tender)
IV.3.8)Conditions for opening tenders

Date: 29.8.2012 – 12:00
Place:

National Procurement, 2 Swinhill Avenue, Larkhall, ML9 2QX.

Section VI: Complementary information

VI.1)Information about recurrence
VI.2)Information about European Union funds
VI.3)Additional information

The estimated value range referred to sections II.1.4 and II.2.1 is for the initial 12 month duration of the Framework Agreement and does not include the extension options.
Please note, Variants will NOT be accepted.
To access the tender documents for this contract notice, please click on the attached link. This will take you to the tender module within Public Contracts Scotland. This will allow you to access and respond to this contract opportunity in a secure environment. Note: If you do not have a password for the tender module then you will be asked to apply for a login.
(www.publictendersscotland.publiccontractsscotland.gov.uk).

(SC Ref:233256).

VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals

Precise information on deadline(s) for lodging appeals: The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2012 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages. Economic operators are entitled to write to the Authority after receipt of the notification should they require further clarification. The Authority will respond within 15 days of such a written request, but it should be noted that receipt by the Authority of such request during the standstill period may not prevent the Authority from awarding the framework agreement following the expiry of the standstill period. Where an economic operator is dissatisfied with the Authority’s response to its request for clarification, or considers that the framework agreement has been concluded in breach of The Public Contracts (Scotland) Regulations 2012, such economic operator is advised to promptly seek independent legal advice.
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:13.7.2012